To screen ETFs by asset class, performance, yield and more, check out the
View as an RSS Feed
Kalobios; A Lost Cause Or Great Opportunity
Assuming the company isn't liquidated immediately, the "product pipeline and sophisticated technology platform" will continue to burn the cash they still have, therefore reducing the value of the company further, the fact that the stock isn't trading at a discount and foreshadowing that trend is because their is still some value ( although greatly diminished) some investors see in the companies future earnings potential or the inherent value of the remaining products the company is developing. From the looks of things, the company is not giving up trying to be successful and develop a ground breaking drug, therefore, the high risk comes from the refusal of the company to liquidate and expend the rest of their financial capital on developing products, therefore rendering the company worthless.
Feb 7, 2014. 05:21 PM
Link to Comment
Xignite quote data
© 2014 Seeking Alpha